Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists
New England Journal of Medicine · 2024
DOI: 10.1056/nejmp2400978 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Ezekiel J Emanuel und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia (E.J.E., J.L.D., M.S.M…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Receptors, Gastrointestinal Hormone, Obesity. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia (E.J.E., J.L.D., M.S.M.); the Bergen Center for Ethics and Priority Setting, University of B…
ORCID-Profile: Matthew S McCoy
Zitieren
APA
Emanuel, E. J., Dellgren, J. L., McCoy, M. S., & Persad, G. (2024). Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists. New England Journal of Medicine. https://doi.org/10.1056/nejmp2400978
Vancouver
Emanuel EJ, Dellgren JL, McCoy MS, Persad G. Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists. New England Journal of Medicine. 2024. doi:10.1056/nejmp2400978
BibTeX
@article{Emanuel2024,
author = {Emanuel, Ezekiel J and Dellgren, Johan L and McCoy, Matthew S and Persad, Govind},
title = {Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmp2400978}
}
EUVIMED